Jose M. Mejia Oneto

Jose M. Mejia Oneto

Y Combinator Logo Batch: W15

Achievements

  • Founded Shasqi in 2015 after participating in Y Combinator's Winter 2015 batch
  • Raised over $60 million in funding for Shasqi
  • Lead drug in Shasqi's pipeline is in Phase 2 clinical trials
  • Holds a Ph.D. in organic chemistry from Emory University
  • Collaborated with Royzen Lab at the University at Albany
  • Received grants from NIH and NSF

Getting real about Jose M. Mejia Oneto

Look, here’s the real scoop on Jose M. Mejia Oneto. This guy is the real deal in biotech startup land. Dude’s a physician-scientist turned entrepreneur who’s been crushing it since day one.

So, he jumped into the scene back in W15 when he rolled with Y Combinator’s winter batch, that’s the same one Tambo, his earlier project, was part of. But then, he pivoted hard and founded Shasqi, a biotech company out in SF that’s all about using click chemistry to fight cancer. No bullshit, they’ve raised over 60 million bucks and their lead drug is already in Phase 2 trials. That’s some serious progress.

What’s wild is, Jose’s not just some guy with a startup. He’s got a legit science background, Ph.D. from Emory in organic chemistry, and he even did clinical work in orthopedics at UC Davis. So, he’s bridging lab stuff with real-world medicine. That kinda mix makes him super unique. He’s worked with top labs like Royzen at Albany, snagged grants from NIH and NSF, and has experience spanning biotech, drug delivery, imaging, even medical devices. Basically, he’s been around the block and knows what it takes to turn crazy science into actual treatments.

Got a startup idea and seeking investment? No Cap is the first AI investor capable of investing in startups by herself.

Talk to her

His story screams motivation. Started out studying at Macalester College, where he met a key collaborator, then went deep into research, building a solid foundation in organic chemistry and medicine. From there, he jumped into startups, always pushing boundaries. Founding Shasqi wasn’t just about making money, it’s about solving some of the toughest cancer problems with original chemistry. You can tell he’s driven by a genuine desire to make a difference, not just chase the next big payday.

So, why is Jose so important? Because he’s blending hardcore science with startup hustle, and he’s doing it at a level most folks only dream of. His work in click chemistry could totally change how we treat cancer, and he’s proven that with real funding and clinical progress. He’s the kind of guy who sees opportunities where others see bullshit, and he’s not afraid to jump in and make shit happen. That’s the essence of a true innovator, someone who’s not just talking but actually doing.

In short, Jose M. Mejia Oneto is a trailblazer. A scientist who turned his knowledge into a startup that’s pushing the boundaries of medicine. He’s the kind of person who reminds us that with enough grit and science, you can really change the game.

Founder ID: 107298

Share your thoughts about Jose M. Mejia Oneto

Have you worked with this founder? Know additional information? Share your insights, experiences, or suggest updates to help the community learn more.

Select your comment type:

Opinion Share your opinion
Professional Experience Professional experience
Additional Insights Additional insights
Suggest Corrections Suggest corrections

If something is wrong about Jose M. Mejia Oneto, there's inaccurate information or there are updates, please let us know, we'll update it for you and everyone ;)

Your email address will not be published. Help us build a comprehensive founder database.